Crossmark

Comparison between the European Randomized Study for Screening of Prostate Cancer (ERSPC) and Prostate Biopsy Collaborative Group (PBCG) risk calculators: Prediction of clinically significant Prostate Cancer risk in a cohort of patients from Argentina

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2023.10.002

Published Print: 2024-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Orbe Villota, P.M.

Leiva Centeno, J.A.

Lugones, J.

Minuzzi, P.G.

Varea, S.M.
License Information

Text and Data Mining valid from 2024-04-01
More Information

This article is maintained by: Elsevier

Article Title: Comparison between the European Randomized Study for Screening of Prostate Cancer (ERSPC) and Prostate Biopsy Collaborative Group (PBCG) risk calculators: Prediction of clinically significant Prostate Cancer risk in a cohort of patients from Argentina

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2023.10.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2023.07.008

Content Type: article

Copyright: © 2023 AEU. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below